Literature DB >> 16369764

Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms.

Riddhish Shah1, Brad Rahaman, Carolyn Katovich Hurley, Phillip E Posch.   

Abstract

Altered TGF-beta1 expression due to polymorphisms affects a wide variety of normal cellular and disease processes such as T cell activation and proliferation, tumor progression, and asthma. In this study, a comprehensive examination of function and diversity was undertaken for the TGFB1 promoter region and exon 1 (-2,665 to +423). The known TGF-beta1 promoter was extended to encompass 463 bases by the identification of a strong enhancer activity for a distal segment (-2,665 to -2,204). Ten novel polymorphisms and 14 novel alleles were identified. Most single nucleotide polymorphisms (SNPs) appear to be randomly associated except c.-768_-769insC and c.+74G > C and a set of five novel polymorphisms present in a single allele in persons of African descent. The TGFB1 alleles clustered into three phylogenetic groups based on the common functional SNPs c.-1347C > T (commonly known as -509C-T) and c.+29T > C (commonly known as +869T-C) suggesting three phenotypic groups. Two SNPs unique to African-Americans affect the TGFB1 regulatory region. The c.-1287G > A SNP in the promoter alters the binding affinity of two unidentified transcription factor complexes which translates into a significant difference in reporter gene expression and the c.-387C > T SNP in the 5' UTR alters the binding of Stimulating protein 1 and 3. Thus, TGFB1 possesses a highly polymorphic, extensive regulatory region that likely impacts the pathogenesis of numerous TGF-beta1 related diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16369764     DOI: 10.1007/s00439-005-0112-y

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  42 in total

Review 1.  The role of transforming growth factor-beta in transplant rejection.

Authors:  I V Hutchinson
Journal:  Transplant Proc       Date:  1999-11       Impact factor: 1.066

Review 2.  Cytokine gene polymorphism in human disease: on-line databases, supplement 2.

Authors:  N Haukim; J L Bidwell; A J P Smith; L J Keen; G Gallagher; R Kimberly; T Huizinga; M F McDermott; J Oksenberg; J McNicholl; F Pociot; C Hardt; S D'Alfonso
Journal:  Genes Immun       Date:  2002-09       Impact factor: 2.676

3.  Association of transforming growth factor-beta1 (TGFbeta1) T29 --> C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal german women.

Authors:  V Hinke; T Seck; C Clanget; C Scheidt-Nave; R Ziegler; J Pfeilschifter
Journal:  Calcif Tissue Int       Date:  2001-12       Impact factor: 4.333

4.  AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells.

Authors:  Cora Weigert; Ulrich Sauer; Katrin Brodbeck; Andreas Pfeiffer; Hans U Häring; Erwin D Schleicher
Journal:  J Am Soc Nephrol       Date:  2000-11       Impact factor: 10.121

Review 5.  Roles of TGF-beta in hepatic fibrosis.

Authors:  Axel M Gressner; Ralf Weiskirchen; Katja Breitkopf; Steven Dooley
Journal:  Front Biosci       Date:  2002-04-01

6.  Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma.

Authors:  Eric S Silverman; Lyle J Palmer; Venkat Subramaniam; Arlene Hallock; Sheeba Mathew; Joseph Vallone; Debora S Faffe; Toshiki Shikanai; Benjamin A Raby; Scott T Weiss; Stephanie A Shore
Journal:  Am J Respir Crit Care Med       Date:  2003-11-03       Impact factor: 21.405

7.  Genetic control of the circulating concentration of transforming growth factor type beta1.

Authors:  D J Grainger; K Heathcote; M Chiano; H Snieder; P R Kemp; J C Metcalfe; N D Carter; T D Spector
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

8.  T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study.

Authors:  Loïc Le Marchand; Christopher A Haiman; David van den Berg; Lynne R Wilkens; Laurence N Kolonel; Brian E Henderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-03       Impact factor: 4.254

9.  Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene.

Authors:  A G Geiser; S J Kim; A B Roberts; M B Sporn
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

10.  Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.

Authors:  M Suthanthiran; B Li; J O Song; R Ding; V K Sharma; J E Schwartz; P August
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  23 in total

1.  Association of Transforming Growth Factor Beta-1 (TGF-β1) Genetic Variation with Type 2 Diabetes and End Stage Renal Disease in Two Large Population Samples from North India.

Authors:  Priyanka Raina; Ruhi Sikka; Ramandeep Kaur; Jasmine Sokhi; Kawaljit Matharoo; Virinder Singh; A J S Bhanwer
Journal:  OMICS       Date:  2015-04-14

2.  A molecular mechanism for the differential regulation of TGF-beta1 expression due to the common SNP -509C-T (c. -1347C > T).

Authors:  Riddhish Shah; Carolyn K Hurley; Phillip E Posch
Journal:  Hum Genet       Date:  2006-08-01       Impact factor: 4.132

3.  The functionality of African-specific variants in the TGFB1 regulatory region and their potential role in HIVAN.

Authors:  M Nel; J-M Buys; F C J Botha; N Wearne; S Prince; J M Heckmann
Journal:  Clin Exp Nephrol       Date:  2017-12-04       Impact factor: 2.801

4.  Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors.

Authors:  Esteban Arrieta-Bolaños; Neema P Mayor; Steven G E Marsh; J Alejandro Madrigal; Jane F Apperley; Keiren Kirkland; Stephen Mackinnon; David I Marks; Grant McQuaker; Julia Perry; Michael N Potter; Nigel H Russell; Kirsty Thomson; Bronwen E Shaw
Journal:  Haematologica       Date:  2015-11-26       Impact factor: 9.941

5.  Conditional radioresistance of Tet-inducible manganese superoxide dismutase bone marrow stromal cell lines.

Authors:  Michael W Epperly; J Richard Chaillet; Ronny Kalash; Ben Shaffer; Julie Goff; Darcy Franicola; Xichen Zhang; Tracy Dixon; Frank Houghton; Hong Wang; Hebist Berhane; Cynthia Romero; Jee-Hong Kim; Joel S Greenberger
Journal:  Radiat Res       Date:  2013-07-17       Impact factor: 2.841

6.  TNF, LTA and TGFB1 genotype distributions among acute graft-vs-host disease subsets after HLA-matched unrelated hematopoietic stem cell transplantation: a pilot study.

Authors:  R Shah; S T Selby; B Yokley; R S Slack; C K Hurley; P E Posch
Journal:  Tissue Antigens       Date:  2009-04-08

7.  TGF-beta1 gene polymorphisms and primary vesicoureteral reflux in childhood.

Authors:  Magdalena Kowalewska-Pietrzak; Izabela Klich; Wojciech Mlynarski
Journal:  Pediatr Nephrol       Date:  2008-08-07       Impact factor: 3.714

8.  The African-387 C>T TGFB1 variant is functional and associates with the ophthalmoplegic complication in juvenile myasthenia gravis.

Authors:  Melissa Nel; Joy-Mari Buys; Robyn Rautenbach; Shaheen Mowla; Sharon Prince; Jeannine M Heckmann
Journal:  J Hum Genet       Date:  2015-12-03       Impact factor: 3.172

Review 9.  TGFB1 genetic polymorphisms and coronary heart disease risk: a meta-analysis.

Authors:  Yingchang Lu; Jolanda M A Boer; Roza M Barsova; Olga Favorova; Anuj Goel; Michael Müller; Edith J M Feskens
Journal:  BMC Med Genet       Date:  2012-05-18       Impact factor: 2.103

10.  Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines.

Authors:  Marcy E Beildeck; Md Islam; Salimuddin Shah; Joellen Welsh; Stephen W Byers
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.